The key technology of Epigeneron is locus-specific chromatin immunoprecipitation (ChIP).
Nikkei Biotech news release, July 15, 2015
Osaka University Venture starts Epigeneron, an epigenetic drug discovery company
The key technology of Epigeneron is locus-specific chromatin immunoprecipitation (ChIP).
Nikkei Biotech news release, July 15, 2015